News | December 15, 2022
Kerala Ayurveda receives US patent for its herbal formulation
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
EC grants conditional marketing authorization based on the EFFISAYIL trial
As per 10th edition of International Diabetes Federation (IDF) Atlas, 2021, India has 74.2 million people with diabetes between the age of 20-79 years
The Institute will focus on increasing preparedness and laboratory capabilities for identification of novel and unknown zoonotic agents
The approval follows the positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) in October 2022
These satellite institutes will further strengthen the research, international collaborations and facilitate affordable Ayush services for the larger community.
More women centric initiatives being the need of the hour for holistic development
Asia’s premier and USA-patented, ANSSI Wellness for spinal decompression was launched in Pune
Application includes data from key phase III trials, including the pivotal MOMENTUM trial, which met all primary and key secondary efficacy endpoints
Phase-III trials were conducted for safety, and immunogenicity in around 3,100 subjects, in 14 trial sites across India (supported by BIRAC)
Subscribe To Our Newsletter & Stay Updated
